CAMP4 Therapeutics Corporation

CAMPNASDAQ · Pharmaceutical Preparations

Financing

SEC filings to 2026-10-05 · every row opens its filing

Shares on issue

51.9M

on 2026-06-30, from 1.01M on 2024-09-30 10-Q ↗

a raise that quarter, at its price

Newest

$300.0M

S-3 of 2025-11-10. 1 prospectus supplement filed under it since. S-3 ↗

$100.0M

Leerink Partners, agreement of 2025-11-10. No at-the-market sales statement read from a 10-Q or 10-K. 424B5 ↗

Warrants

142

Warrants of every class as tagged in the XBRL facts on 2025-12-31. 10-K ↗

Cash

12.1 quarters

$86.4M on 2026-06-30 ÷ $7.1M a quarter of operating cash used, the average of four quarters. 10-Q ↗

Raised
Date	What	Shares	Price	Gross	Filing
2025-12-18	Public offering	5,000,000	$6.00	$30.0M	424B5 ↗
2025-09-10	Private placement incl. 6.00M pre-funded	32,684,811	$1.53	$50.1M	8-K ↗